These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5766228)

  • 21. Sorbitol in bulk compounding formulations.
    Am J Hosp Pharm; 1967 Jul; 24(7):378. PubMed ID: 6043708
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of an aerosol product development kit in bulk compounding.
    Am J Hosp Pharm; 1970 Apr; 27(4):324-6. PubMed ID: 5446268
    [No Abstract]   [Full Text] [Related]  

  • 23. Some theoretical aspects of bulk compounding technology. II. Suspensions.
    Am J Hosp Pharm; 1969 Sep; 26(9):548-50. PubMed ID: 5823458
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescription compounding by nurses in hospitals.
    Rprovost GP
    Am J Hosp Pharm; 1966 Nov; 23(11):595. PubMed ID: 5979849
    [No Abstract]   [Full Text] [Related]  

  • 25. Some theoretical aspects of bulk compounding technology. 3. Emulsions.
    Schumacher GE
    Am J Hosp Pharm; 1970 Jan; 27(1):64-6. PubMed ID: 5411640
    [No Abstract]   [Full Text] [Related]  

  • 26. The expanding role of pharmacy. Interview by Nancy Agresta.
    Durgin J
    Hosp Formul; 1980 Apr; 15(4):287-90, 293. PubMed ID: 10245911
    [No Abstract]   [Full Text] [Related]  

  • 27. Battles over compounding from bulk drugs move forward.
    Clark A
    J Am Vet Med Assoc; 2005 Jul; 227(1):9-10. PubMed ID: 16013529
    [No Abstract]   [Full Text] [Related]  

  • 28. Some theoretical aspects of bulk compounding technology. I. Ionic equilibria, pH and choice of solvents.
    Am J Hosp Pharm; 1969 Jun; 26(6):354-6. PubMed ID: 5797289
    [No Abstract]   [Full Text] [Related]  

  • 29. Extemporaneous mixing of injectables by physicians and pharmacists.
    Meyers EL
    Bull Parenter Drug Assoc; 1965; 19(6):164-71. PubMed ID: 5837810
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug supply chain safety in hospitals: current data and experience of the Grenoble university hospital].
    Bedouch P; Baudrant M; Detavernier M; Rey C; Brudieu E; Foroni L; Allenet B; Calop J
    Ann Pharm Fr; 2009 Jan; 67(1):3-15. PubMed ID: 19152845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive intravenous admixture services: logistics and quality assurance in a university affiliated teaching institution.
    Wellman GS; Hale KM; Schneider PJ; Hale KN
    Hosp Pharm; 1984 Sep; 19(9):601-6. PubMed ID: 10267935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dilemmas in compounding for the veterinary teaching hospital.
    Kemp DT
    J Am Vet Med Assoc; 1994 Jul; 205(2):263-7. PubMed ID: 7928595
    [No Abstract]   [Full Text] [Related]  

  • 33. Society of Hospital Pharmacists of Australia: are you at risk?
    Aust Hosp; 1981 Jul; (54):4-5. PubMed ID: 10254354
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible occupational hazards associated with the preparation/administration of antineoplastic agents.
    Crudi CB; Stephens BL; Maier P
    NITA; 1982; 5(4):264-5. PubMed ID: 6922411
    [No Abstract]   [Full Text] [Related]  

  • 35. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint commission to survey compliance with new USP-NF Chapter on compounding sterile preparations.
    Jt Comm Perspect; 2004 Apr; 24(4):4-5. PubMed ID: 15085694
    [No Abstract]   [Full Text] [Related]  

  • 37. American hospital pharmacy from the Colonial period to the 1930s.
    Higby GJ
    Am J Hosp Pharm; 1994 Nov; 51(22):2817-23. PubMed ID: 7856607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug manufacturing in hospitals.
    Gillespie BJ
    Can J Hosp Pharm; 1985 Apr; 38(2):42. PubMed ID: 10270940
    [No Abstract]   [Full Text] [Related]  

  • 39. Compounded medicines and 'off label' prescribing - a case for more guidance.
    Fois RA; Mewes BT; McLachlan AJ; Ramzan I
    Aust Fam Physician; 2009; 38(1-2):16-20. PubMed ID: 19283230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
    Costentin J
    Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.